Idera Pharmaceuticals holder Pillar Invest purchased 800K shares, while ChemoCentryx holder Vifor sold 260K shares Welcome to "Fly Insider," The Fly's weekly recap of notable insider stock transactions.
NOTABLE INSIDER PURCHASES: Significant insider purchases reported in the prior week from July 13 through July 17 include:
- CEO of Postal Realty Trust (PSTL) Andrew Spodek purchased 78,195 shares of company stock at $13.03 per share for a total transaction value of 1,018,928 8%
- Beneficial owner of Nkarta (NKTX) GlaxoSmithKline purchased 833,333 shares of company stock at $18.00 per share for a total transaction value of $14,999,994
- Director of nCino (NCNO) Steven Collins purchased 32,250 shares of company stock at $31.00 per share for a total transaction value of $999,750
- CEO of Perspecta (PRSP) John Curtis purchased 18,354 shares of company stock at $21.97 per share for a total transaction value of $403,237
- Beneficial owner of Idera Pharmaceuticals (IDRA) Pillar Invest purchased 749,993 shares of company stock at $1.72 per share for a total transaction value of $1,289,988.
NOTABLE INSIDER SALES: Significant insider sales reported in the prior week from July 13 through July 17 include:
- Beneficial owner of Turning Point Brands (TPB) Standard Diversified sold 1,800,000 shares of company stock at $22.44 per share for a total transaction value of $40,396,500
- CFO of Paychex (PAYX) Efrain Rivera sold 28,482 shares of company stock at $73.35 per share for a total transaction value of $2,089,155
- Chairman of Zoom Video (ZM) Eric Yuan sold 140,286 shares of company stock at $250.64 per share for a total transaction value of $35,160,890
- Beneficial owner of ChemoCentryx (CCXI) Vifor sold 259,798 shares of company stock at $58.15 per share for a total transaction value of $15,106,059
- Director of Okta (OKTA) Michelle Wilson sold 30,000 shares of company stock at $203.56 per share for a total transaction value of $6,106,839
NOTABLE PRICE MOVEMENT AFTER INSIDER TRANSACTION: Shares of Idera Pharmaceuticals are up 50% after beneficial owner Pillar Invest purchased shares, while shares of ChemoCentryx are down 3% after beneficial owner Vifor sold shares.
Symbols:
PSTL NKTX NCNO PRSP IDRA TPB OKTA CCXI ZM - $270.24 /
+23.61 (+9.57%)
PAYX Keywords: insider trading, insider buying, insider selling, executive trading, executive buying, executive selling, stock transactions, SEC